NCT00422994View on ClinicalTrials.gov

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Restless Legs Syndrome

Interventions

DRUG

ropinirole dosing for up to 28 days

Trial Locations (2)

55404

GSK Investigational Site, Minneapolis

SW17 0QT

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY